We are live on ! Find out more
NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

70 hedge funds and large institutions have $78M invested in Northwest Biotherapeutics, Inc. Common stock in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 11

80% more capital invested

Capital invested by funds: $43.3M → $78M (+$34.7M)

20% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $1.92M

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

1% less funds holding

Funds holding: 71 → 70 (-1)

Holders
70
Holders Change
-1
Holders Change %
-1.41%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
26
Reduced
11
Closed
11
Calls
$2.31M
Puts
$1.92M
Net Calls
+$387K
Net Calls Change
+$1.3M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.17M
2
BFA
BlackRock Fund Advisors
California
+$1.1M
3
BIT
BlackRock Institutional Trust
California
+$737K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$496K
5
American Century Companies
American Century Companies
Missouri
+$445K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$5.16M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.18M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$888K
4
MAM
Majedie Asset Management
United Kingdom
-$757K
5
TCIM
TIAA CREF Investment Management
New York
-$390K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$269K – – –
CDH
27
Charles D. Hyman
$221K – – –
Chevy Chase Trust
28
Chevy Chase Trust
Maryland
$197K – – –
AllianceBernstein
29
AllianceBernstein
Tennessee
$185K – – –
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$159K +$5.25K +1,025 +4%
MLICM
31
Metropolitan Life Insurance Company (MetLife)
New York
$157K – – –
NFA
32
Nationwide Fund Advisors
Ohio
$156K +$7.27K +1,421 +5%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$148K – – –
WC
34
Woodstock Corp
Massachusetts
$140K – – –
AIG
35
American International Group
New York
$130K +$4.64K +907 +4%
BA
36
BlackRock Advisors
Delaware
$111K +$3.14K +613 +3%
LWM
37
Lyons Wealth Management
Florida
$107K +$102K +20,000 New
CS
38
Credit Suisse
Switzerland
$101K +$96.6K +18,876 New
BFG
39
Bouchey Financial Group
New York
$84K – – –
UBS Group
40
UBS Group
Switzerland
$84K +$80.4K +15,703 New
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$83K – – –
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$78K -$56.6K -11,053 -43%
VKH
43
Virtu KCG Holdings
New York
$77K -$89.5K -17,489 -55%
MC
44
Moors & Cabot
Massachusetts
$77K -$31.7K -6,200 -29%
AL
45
Airain Ltd
Guernsey
$61K -$81.7K -15,975 -58%
GC
46
Guggenheim Capital
Illinois
$58K +$55.5K +10,851 New
WS
47
Wedbush Securities
California
$56K -$76.8K -15,000 -59%
Citigroup
48
Citigroup
New York
$46K +$24.8K +4,848 +127%
Citadel Advisors
49
Citadel Advisors
Florida
$44K +$8.03K +1,569 +23%
Wells Fargo
50
Wells Fargo
California
$40K +$20.5K +4,014 +117%
1
2
3 4

NWBO Hedge Fund Activity: Q4 2014 in Review

70 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q4 2014, worth a combined $78M — up 80% from $43.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NWBO positions and 11 closed out — a net gain of 1 holder — while 26 added to existing stakes and 11 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $1.17M. The largest seller was Franklin Resources, exiting entirely with an estimated $5.16M sold.

  • 70 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q4 2014, down from 71 in Q3 2014.
  • Funds reported $78M of Northwest Biotherapeutics, Inc. Common stock stock for Q4 2014, up 80% quarter-over-quarter.
  • 12 funds opened new Northwest Biotherapeutics, Inc. Common stock positions in Q4 2014 and 11 closed out, a net change of +1 holder.
  • The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q4 2014 was Goldman Sachs, an estimated $1.17M added.
  • The largest Northwest Biotherapeutics, Inc. Common stock seller in Q4 2014 was Franklin Resources, an estimated $5.16M sold.

Based on aggregated 13F filings for Q4 2014.